The Costs of Cancer for People with Limited Incomes
As a leading cause of death and disease in the U.S., cancer takes a huge toll on the health of patients and survivors, and it also has a great impact on their finances. The costs of cancer do not impact all patients equally. Evidence consistently shows that certain factors – like race/ethnicity, health insurance status, income and where a person lives – impact cancer diagnosis, treatment, survival and financial hardship experienced by people with cancer and their families. This fact sheet explores the costs of cancer on people with limited incomes, which unless otherwise indicated include individuals whose annual income is equal to or less than 400% of the Federal Poverty Level (FPL).1
People facing cancer and survivors with limited incomes experience higher health care costs and significantly more financial hardship compared to individuals who have not been diagnosed with cancer.
Overall, cancer survivors with limited incomes have significantly more health care expenditures, or costs, than people with limited incomes who have not been diagnosed with cancer (almost triple the amount in younger ages).2
Annual Average Health Care Expenditures for Individuals with Limited Incomes
I had a family with kids. We lost everything due to my medical debt. The hospital turned me away when I showed up for my surgery. They said I had an old outstanding bill for $800. There I was, in the lobby, ready to have my cancer removed with no way to pay the money. I knew I needed the surgery to save my life, but the hospital was drawing a line in the sand. Luckily, my mother was there with me and allowed me to borrow the money from her so that I could have surgery. Otherwise, I’m not sure I’d be here.
Melissa Taylor, Florida
Cancer’s Impact on People with Limited Incomes
Residents of limited-income areas share an unequal burden of cancer deaths. Persistent poverty is linked with increased rates of cancer deaths.3 The reasons for higher rates of cancer incidence and mortality in limited-income areas are multidimensional and influenced by adverse differences in social determinants of health.
- U.S. counties that experience persistent poverty have higher mortality rates for all cancer types (12.3% higher), as well as for cancers of lung (16.5% higher), colorectal (17.7% higher), stomach (43.2% higher) and liver and intrahepatic bile duct (27.6% higher).4
- Cancer death rates vary significantly in counties of different income levels, with a mean cancer death rate per 100,000 person-years of 185.9 in high-income counties, 204.9 in medium-income counties, and 229.7 in low-income counties.5
Cancer Death Rates, 2016-2017
Health Insurance Coverage Among People with Limited Incomes
The details of an individual’s health insurance coverage – or lack thereof – have a huge impact on what costs that person pays for treating their cancer.
- Patients who are uninsured are responsible for all of their treatment costs, which can be very large sums of money. In 2012-2014, 6.1% of individuals with incomes lower than 200% FPL and 3% of individuals with incomes 201- 400% FPL newly diagnosed with cancer were uninsured – compared to only 1.4% of those with higher incomes.6
- For those individuals with limited incomes who are insured, the type and details of their insurance coverage can determine a great deal of their costs. Those with the most limited incomes are more likely to be eligible for, and therefore enrolled in, Medicaid or other public insurance, where their out-of-pocket costs are also limited.
- More and more individuals are enrolled in high-deductible health plans (HDHPs), despite their high upfront costs and mounting evidence that these plans cause patients to delay important cancer care and have worse cancer outcomes.7, 8, 9 Nearly 45% of privately insured cancer survivors with incomes 200-399% FPL have an HDHP.10
Insurance Type, Individuals with Limited Incomes and a History of Cancer, Ages 18-64
What Patients & Survivors with Limited Incomes Pay Out-of-Pocket for Care
Cancer treatment is often complex, involves many services and is expensive. Research consistently shows that individuals who have been diagnosed with cancer have higher out-of-pocket costs than those without a cancer history.11 These increased costs often continue even years after the patient has finished active cancer treatment.
- Younger people with a cancer history and limited incomes spend significantly more out-of-pocket than individuals without a cancer history (this does not include monthly health insurance premiums).12 People over the age of 65 with incomes less than 200% FPL pay the highest amount of annual average out-of-pocket expenses: $2,017. This amount is higher than the average amount paid by their higher-income counterparts.13
Average Annual Out-of-Pocket Expenses, Individuals Ages 18-64 with Limited Incomes
The Impacts of the Costs of Cancer on Individuals with Limited Incomes
The high costs of cancer have many adverse impacts. Research shows that individuals ages 18-64 with a history of cancer experience significantly more financial hardship than individuals without a cancer history:14
ACS CAN Supports Policies That Will Reduce the Costs of Cancer in Individuals with Limited Incomes
The American Cancer Society Cancer Action Network (ACS CAN) wants to make sure that everyone has a fair and just opportunity to prevent, detect, treat and survive cancer. To reduce the costs of cancer in individuals with limited incomes, ACS CAN supports:
- Expanding Medicaid in the 12 remaining states that have not done so. The health coverage provided by Medicaid helps to improve outcomes and reduce the burden of cancer by offering access to prevention services and timely cancer screening and early detection services, as well as affordable treatment services and care. In 12 states, there are more than 2.2 million people who should be able to see a doctor but cannot. They don’t qualify for Medicaid, but also don’t fall into the income bracket that allows them to receive marketplace subsidies. This is the Medicaid coverage gap – 60% of these uninsured individuals are people of color, and the vast majority live in the American South, which includes a large Black/African American population. All states should expand Medicaid, and Congress must close the coverage gap for lower income Americans who live in states that have failed to expand.
- Making expanded marketplace subsidies permanent. The recent Inflation Reduction Act has extended increased subsidies for three more years (through December 31, 2025), making premiums and cost sharing more affordable for millions of people. However, this extension is not permanent. People who need health insurance coverage through the marketplace need these subsidies to be permanent so their costs will stay affordable and they aren’t in danger of losing coverage.
-
Ensuring working people with cancer, survivors and caregivers
have paid leave. Cancer treatment is time consuming – often
requiring time off from work for doctor’s visits, surgery and
recovery, chemotherapy and radiation. The flexibility to balance
cancer treatment and employment is essential. Studies show that people
with cancer who have paid leave have higher rates of job retention and
lower rates of financial burden.15,
16 Yet not all people facing cancer,
survivors and caregivers who work have access to paid leave, and
without it they risk losing employment or not getting the care they
need. ACS CAN supports policies at the national, state and local
levels that increase access to job-protected paid family and medical
leave that can be used for cancer treatments, survivorship care and
caregiving, as well as other illnesses.
A previous ACS CAN survey showed that respondents who were less likely to report having paid family and medical leave were those with lower levels of income, and respondents who reported having issues with cancer/caregiving and their job – including the quality of their work suffering, having to take two or more days off of work in a row, or having to leave work early – most often tended to be those in lower-income households.17
- Addressing patient costs to diversify participation in clinical trials. While patient willingness to enroll in clinical trials is high, some people with cancer decline due to costs. They are frequently responsible for non-medical costs such as transportation and lodging associated with trial enrollment. These costs can occur when no local trials are available and patients have to travel to distant trial sites, or when there is a need for more frequent clinic visits for additional trial-related treatment or monitoring. The additional costs can lead to unequal participation rates between high- and limited- income people facing cancer and the patients most impacted tend to be those traditionally underrepresented. To address this issue, the DIVERSE Trials Act would allow clinical trial sponsors to provide financial support to trial participants and the technology needed to participate in trials remotely. Offering to reimburse patients for non- medical costs associated with trials can increase overall enrollment and thereby help make it less costly for patients to access innovative therapies through clinical trials during their cancer treatment. The bill also further requires the FDA to issue guidance on the use of decentralized trial tools to address disparities in clinical trial participation. This guidance would help make participation in clinical trials easier for patients by reducing or removing the need to travel to specific trial sites.
- Improving access to and ensuring long-term sustainable payment of patient navigation services. Patient navigation has become increasingly recognized for improving patient outcomes, reducing unnecessary treatment costs and increasing patient satisfaction. However, patient navigation is still absent or limited in many cancer programs and hospital settings due to cost concerns and a lack of long-term funding to pay for these services. Instead, patient navigation programs are often financed via short-term funding like private or governmental grants. ACS CAN supports and advocates to improve health equity by increasing access to quality cancer care among communities that have been under-resourced by extending the reach of navigation services. The expansion and sustainability of patient navigation services will only be achieved by ensuring that these services can be paid for the long term, thereby ensuring everyone everywhere will have access to the patient navigation services needed to ensure better patient experience and outcome due to a cancer diagnosis.
In Their Own Words: Experience with Costs and Debt
The American Cancer Society Cancer Action Network (ACS CAN) gives voice to people with cancer and survivors on critical public policy issues that affect their lives. In February 2022 we conducted a survey of cancer survivors on cost and debt issues. Cancer sur- vivors with limited incomes18 told us they had problems affording treatment, dealing with worry and anxiety and medical debt.19
Problems affording treatment
It was difficult to afford my health care expenses. 44%
The cost of a treatment influences whether I get a treatment that my health care provider recommends. 46%
I delayed or did not pay other household expenses (like utility bills) to use the money for health care costs instead. 18%
Medical debt
I have current or past medical debt associated with my cancer care. 58%
- I have been contacted by a collections agency about debt related to my cancer care. 54%*
- I declared bankruptcy due to health care costs or debts. 5%*
*Note: This is the percentage of survey respondents who indicated they have current or past medical debt.
Worry and anxiety
I am concerned about my ability to pay for current or future health care costs related to my cancer. 77%
I am concerned about incurring new debt for my cancer care. 74%
References
-
In 2022, the FPL for a family of one is $13,590. For more information, please visit: https://aspe.hhs.gov/topics/poverty-economic-mobility/poverty-guidelines.
-
Agency for Healthcare Research and Quality: Medical Expenditure Panel Survey, 2018-2019. Public-use data file and documentation. Retrieved from: https://meps.ahrq.gov/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-216. July 2022.
-
Moss JL, Pinto CN, Srinivasan S, Cronin KA, Croyle RT. Persistent Poverty and Cancer Mortality Rates: An Analysis of County Level Poverty Designations. Cancer Epidemiol Biomarkers Prev 2020;29:1949-54.
-
Ibid.
-
O’Connor JM, Sedghi T, Dhodapkar M, Kane MJ, Gross CP. Factors Associated With Cancer Disparities Among Low-, Medium-, and High- Income US Counties. JAMA Netw Open. 2018;1(6):e183146. doi:10.1001/ jamanetworkopen.2018.3146.
-
Mallin K, Browner A, Palis B, et al: Incident cases captured in the national cancer database compared with those in U.S. Population based central cancer registries in 2012-2014. Ann Surg Oncol 26:1604-1612, 2019.
-
Zheng, S; Ren, ZJ; Heineke, J; Geissler, KH. Reductions in Diagnostic Imaging with High Deductible Health Plans. Medical Care. February 2016 - Volume 54 - Issue 2 - p 110–117. doi: 10.1097/MLR.0000000000000472
-
Zheng Z, Jemal A, Banegas MP, Han X, Yabroff KR. High-Deductible Health Plans and Cancer Survivorship: What Is the Association With Access to Care and Hospital Emergency Department Use?. J Oncol Pract. 2019 Aug 8;:JOP1800699. doi: 10.1200/JOP.18.00699. [Epub ahead of print] PubMed PMID: 31393809.
-
Wharam JF et al. Vulnerable And Less Vulnerable Women In High- Deductible Health Plans Experienced Delayed Breast Cancer Care. March 2019. Health Affairs. https://doi.org/10.1377/hlthaff.2018.05026.
-
National Center for Health Statistics: National Health Interview Survey, 2019-2020. Public-use data file and documentation. Retrieved from: https://www.cdc.gov/nchs/nhis/2020nhis.htm. July 2022.
-
Ekwueme DU, Zhao J, Rim SH, de Moor JS, Zheng Z, Khushalani JS, Han X, Kent EE, Yabroff KR. Annual Out-of-Pocket Expenditures and Financial Hardship Among Cancer Survivors Aged 18-64 Years - United States, 2011-2016. MMWR Morb Mortal Wkly Rep. 2019 Jun 7;68(22):494-499. doi: 10.15585/mmwr. mm6822a2. PMID: 31170127; PMCID: PMC6553808.
-
Agency for Healthcare Research and Quality: Medical Expenditure Panel Survey, 2018-2019. Public-use data file and documentation. Retrieved from: https://meps.ahrq.gov/data_stats/download_data_files_detail.jsp?cboPufNumber=HC-216. July 2022.
-
Ibid.
-
Note that all differences between populations presented in this graphic are statistically significant. Source for all data in this section: National Center for Health Statistics: National Health Interview Survey, 2019-2020. Public-use data file and documentation. Retrieved from: https://www.cdc.gov/nchs/nhis/2020nhis.htm. July 2022.
-
Veenstra CM, Regenbogen SE, Hawley ST, Abrahamse P, Banerjee M, Morris AM. Association of Paid Sick Leave With Job Retention and Financial Burden Among Working Patients With Colorectal Cancer. JAMA. 2015 Dec 22 29;314(24):2688-90. doi: 10.1001/jama.2015.12383. PubMed PMID: 26717032.
-
Veenstra, C.M., Abrahamse, P., Wagner, T.H., Hawley, S.T., Banerjee, M. & Morris, A.M. (2018). Employment Benefits and Job Retention: Evidence Among Patients With Colorectal Cancer. Cancer Med. 2018 Mar; 7(3): 736–745. doi: 10.1002/cam4.1371.
-
See Public Opinion Strategies. Key Findings –National Survey of Cancer Patients, Survivors and Caregivers. December 8, 2017. https://www.fightcancer.org/sites/default/files/ACS CAN Paid Leave Surveys Key Findings Press Memo FINAL.pdf .
-
For the data in this section, “limited incomes” is defined as a reported income of under $35,000 per year.
-
Survivor Views web survey, May 16-26, 2022, 2,611 cancer patients and survivors nationwide including 1,370 oversampled by race, ethnicity, and income.
Support for this project was provided by Bristol Myers Squib.